Outbound Pharma’s “Meet for Epilepsy” Campaign to Benefit Epilepsy Foundation

BOWIE, MD, March 13, 2024 — Outbound Pharma, a life sciences boutique firm specializing in business development and lead generation, is launching a charity campaign, “Meet for Epilepsy” to benefit the Epilepsy Foundation.  

"We are thrilled to collaborate with the Epilepsy Foundation for our quarterly give-back campaign," said Dr. Claudio Rota, founder and managing director at Outbound Pharma. “With the “Meet for Epilepsy” campaign, we aim to support the Foundation in its efforts to promote awareness and inspire action in the fight against epilepsy while driving more collaborations and dialogues among industry leaders.”

Outbound Pharma’s campaign is designed to accelerate collaborations and partnerships between industry players, service providers, and the biopharmaceutical community to benefit people with epilepsy.

For every meeting Outbound Pharma schedules between industry partners, Outbound Pharma will donate 10% to the Epilepsy Foundation.

About Outbound Pharma
Outbound Pharma is a life sciences consultancy offering a full suite of services designed to empower your business development and partnering efforts. From lead generation to multi-pronged business development and marketing, we have the expertise you need to stay ahead and build more connections.

Why Outbound Pharma:

• Proven Track Record: With a stellar track record of delivering leads for clients across the life science industry, we know what it takes to turn challenges into triumphs.
• Holistic Approach: Our comprehensive suite of business development and marketing services ensures we can meet all your partnering needs under one roof, saving you money, time, and effort.
• Cutting-Edge Technology Stack: Stay ahead of the competition with our comprehensive suite of lead-gen tools designed to leverage the latest technologies and industry best practices.
• Client-Centric Focus: Your success is our success. We pride ourselves on our client-centric approach, with a win-win engagement model designed to maximize your return on investment without the upfront costs
  For more information, please visit our website at www.outboundpharma.com. To learn more about our efforts to raise money for the EF, please send us a message to info@outboundpharma.com.

About Epilepsy:

According to the World Health Organization, epilepsy is the most common serious brain disorder worldwide with no age, racial, social class, national or geographic boundaries. The U.S. Centers for Disease Control & Prevention (CDC) estimates that 3.4 million people in the United States are affected by epilepsy. Epilepsy is the underlying tendency of the brain to produce seizures which are sudden abnormal bursts of electrical energy that disrupt brain functions.

About the Epilepsy Foundation:

With a network of partners throughout the United States, the Epilepsy Foundation is leading the fight to overcome the challenges of living with epilepsy. The Foundation connects people to treatment, support, and resources; leads advocacy efforts; funds innovative research and the training of specialists; and educates the public about epilepsy and seizure first aid. For more than five decades, the Epilepsy Foundation has shone a light on epilepsy to promote awareness and understanding, and to advocate for laws that matter to people with epilepsy, while also funding epilepsy research and supporting epilepsy investigators and specialists in their early careers. In partnership with the CDC, the Epilepsy Foundation has helped to improve access to care for people with epilepsy, expanded its digital reach and online resources in homes across the country, and trained more than 600,000 people in seizure recognition and first aid. The Epilepsy Foundation has also assisted more than 140,000 people through its 24/7 Helpline, and continues to focus on innovation, new therapies, community services, advocacy and education as key priorities. To learn more visit epilepsy.com or call 1.800.332.1000; in Spanish at 866.748.8008 or laepilepsia.org. Follow us on Facebook, Instagram, Twitter, LinkedIn, TikTok, and YouTube.